Health  Vol.8 No.11 , August 2016
Cost of Treatment of Chronic Spontaneous Urticaria in Turkey
Abstract: Chronic Spontaneous Urticaria (CSU) is a chronic disease with significant negative impact on quality of life of patients. The direct and indirect costs of the disease can be substantial both for the health care system and society. The aim of this research is to estimate the cost of mild, moderate and severe CSU in Turkey and to forecast the cost of the disease from the payer (Social Security Institution—SSI) perspective. Expert opinions with Delphi technique were used in order to determine the cost items and their frequency. A questionnaire was designed to outline resources used in the out-patient, inpatient and emergency care episodes and was answered by dermatologists followed by a consensus meeting. Unit costs were calculated from the price list of the SSI. The annual total cost of treating the disease to the SSI was estimated as 262,111,978TL (94,417,870€) comprising 0.06% of the total healthcare budget in 2013. Since there is limited information about the cost of CSU in Turkey, the methodology and results of this study are unique and very important.
Cite this paper: Tatar, M. , Şentürk, A. , Oğuzhan, G. , Tuna, E. , Mat, C. , Başkan, E. , Artüz, F. , Gürer, M. , Atakan, N. , İnalöz, S. , Çavuşoğlu, S. , Keskinaslan, A. and Şaylan, İ. (2016) Cost of Treatment of Chronic Spontaneous Urticaria in Turkey. Health, 8, 1098-1103. doi: 10.4236/health.2016.811114.

[1]   Zazzali, J.L., et al. (2012) Cost, Utilization, and Patterns of Medication Use Associated with Chronic Idiopathic Urticaria. Annals of Allergy, Asthma & Immunology, 108, 98-102.

[2]   Zuberbier, T., et al. (2009) Dermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. EAACI/ GA(2)LEN/EDF/WAO Guideline: Definition, Classification and Diagnosis of Urticarial. Allergy, 64, 1417-1426.

[3]   Staubach, P., et al. (2006) Quality of Life in Patients with Chronic Urticaria Is Differentially Impaired and Determined by Psychiatric Comorbidity. British Journal of Dermatology, 154, 294-298.

[4]   Weldon, D.R. (2006) Quality of Life in Patients with Urticaria. Allergy & Asthma Proceedings, 27, 96-99.

[5]   Humphreys, F. and Hunter, J.A. (1998) The Characteristics of Urticaria in 390 Patients. British Journal of Dermatology, 138, 635-638.

[6]   Laura, K., et al. (2008) Annual Direct and Indirect Health Care Costs of Chronic Idiopathic Urticaria. Archives of Dermatology, 144, 35-39.

[7]   Mauer, M. (2014) Optimizing the Patient Journey in Chronic Spontaneous Urticaria. Dermatology, 2, 35-40.

[8]   Toubi, E., et al. (2004) Clinical and Laboratory Parameters in Predicting Chronic Urticaria Duration: A Prospective Study of 139 Patients. Allergy, 59, 869-873.

[9]   Greaves, M. (2000) Chronic Urticaria. Journal of Allergy and Clinical Immunology, 105, 664-672.

[10]   Kang, M.J., et al. (2009) The Im-pact of Chronic Idiopathic Urticarial on Quality of Life in Korean Patients. Annals of Dermatology, 21, 226-229.

[11]   Mauer, M., et al. (2011) Unmet Clinical Needs in Chronic Spontaneous Urticaria. A GALEN Task Force Report. Allergy, 66, 317-330.

[12]   Engin, B., et al. (2008) The Levels of Depression Anxiety and Quality of Life in Patients with Chronic Idiopathic Urticaria. JEADV, 22, 38-40.

[13]   Ozkan, M. (2007) Psychiatric Morbidity and Quality of Life in Patients with Chronic Spontaneous Urticaria. Annals of Allergy, Asthma & Immunology, 99, 29-33.

[14]   Hergüner, S., et al. (2011) Levels of Depression, Anxiety and Behavioural Problems and Frequency of Psychiatric Disorders in Children with Chronic Idiopathic Urticarial. British Association of Dermatologists, 164, 1342-1347.

[15]   Grattan, C.E. and Humphreys, F. (2007) British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for Evaluation and Management of Urticaria in Adults and Children. British Journal of Dermatology, 157, 1116-1123.

[16]   Kozel, M.M., Bossuyt, P.M.M., Mekkes, J.R. and Bos, J.D. (2003) Laboratory Tests and Identified Diagnoses in Patients with Physical and Chronic Urticaria and Angioedema: A Systematic Review. Journal of the American Academy of Dermatology, 48, 409-416.

[17]   Zuberbier, T., et al., Dermatology Section of the European Academy of Allergology and Clinical Immunology, Global Allergy and Asthma European Network, European Dermatology Forum and World Allergy Organization (2009) EAACI/GA(2)LEN/EDF/WAO Guideline: Management of Urticaria. Allergy, 64, 1427-1443.

[18]   Powell, R.J., et al. (2007) BSACI Guidelines for the Management of Chronic Urticaria and Angio-Oedema. British Society for Allergy and Clinical Immunology. Clinical & Experimental Allergy, 37, 631-650.

[19]   DeLong, L.K., Culler, S.D., Saini, S.S., Beck, L.A. and Chen, S.C. (2008) Annual Direct and Indirect Health Care Costs of Chronic Idiopathic Urticaria. Acta Dermato-Venereologica, 144, 35-39.

[20]   De Villiers, M., de Villiers, P.J.T. and Kent, A.P. (2005) The Delphi Technique in Health Sciences Education Research. Medical Teacher, 27, 639-643.

[21]   Powell, C. (2002) The Delphi Technique: Myths and Re-alities. Journal of Advanced Nursing, 41, 376-382.

[22]   Sosyal Guvenlik Kurumu Istatistik Bilgileri.

[23]   Sosyal Guvenlik Kurumu (2013) Sosyal Güvenlik Kurumu Bakis Acisi ile Diyabet. SGK, Ankara.